EARLY is the world’s pioneer provider of VM (Volatile Markers) test for early detection of cancer. 

The key to fighting cancer is early detection, meaning finding the disease when it is still curable. Our test is specially designed to meet the needs and demands of large-scale population/targeted screening programs, by being acceptable, affordable and accessible. 

With a simple, safe, highly sensitive, inexpensive urine test, EARLY’s proprietary evidence-based novel platform will enable diagnostic level testing on a population screening scale. 
The company’s test will revolutionize the way cancer is detected, starting with lung cancer, and dramatically reduce the disease’s global human and financial burden.

In the future, the same technology will be modified to allow detection of other cancer types, creating a unique multi-cancer screening platform.



Biotechnology

EARLY Labs

Org chart

Teams

Offices